- Home
- CLPS vs ENLV Comparison
CLPS vs ENLV Comparison
Compare CLPS & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- ENLV
- Stock Information
- Founded
- CLPS 2005
- ENLV 2005
- Country
- CLPS Hong Kong
- ENLV Israel
- Employees
- CLPS N/A
- ENLV N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- ENLV Health Care
- Exchange
- CLPS Nasdaq
- ENLV Nasdaq
- Market Cap
- CLPS 31.2M
- ENLV 27.3M
- IPO Year
- CLPS 2018
- ENLV 1995
- Fundamental
- Price
- CLPS $1.21
- ENLV $1.13
- Analyst Decision
- CLPS
- ENLV Strong Buy
- Analyst Count
- CLPS 0
- ENLV 2
- Target Price
- CLPS N/A
- ENLV $9.50
- AVG Volume (30 Days)
- CLPS 16.5K
- ENLV 105.9K
- Earning Date
- CLPS 03-04-2025
- ENLV 11-29-2024
- Dividend Yield
- CLPS 10.74%
- ENLV N/A
- EPS Growth
- CLPS N/A
- ENLV N/A
- EPS
- CLPS N/A
- ENLV N/A
- Revenue
- CLPS $142,812,726.00
- ENLV N/A
- Revenue This Year
- CLPS N/A
- ENLV N/A
- Revenue Next Year
- CLPS N/A
- ENLV N/A
- P/E Ratio
- CLPS N/A
- ENLV N/A
- Revenue Growth
- CLPS N/A
- ENLV N/A
- 52 Week Low
- CLPS $0.68
- ENLV $0.81
- 52 Week High
- CLPS $1.70
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- CLPS 61.75
- ENLV 42.22
- Support Level
- CLPS $1.08
- ENLV $1.10
- Resistance Level
- CLPS $1.18
- ENLV $1.19
- Average True Range (ATR)
- CLPS 0.05
- ENLV 0.06
- MACD
- CLPS 0.01
- ENLV -0.01
- Stochastic Oscillator
- CLPS 100.00
- ENLV 17.65
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.